Aurobindo Pharma

The new injectable facility of Eugia Steriles Private Limited, a 100% subsidiary of Eugia Pharma Specialities Limited and a step down subsidiary of Aurobindo Pharma Limited, situated at Parawada Mandal, Anakapalli District, Andhra Pradesh, which was inspected by the USFDA from March 28, 2024 to April 5, 2024, has now received its first product approval from the USFDA for Lidocaine Hydrochloride Injection, USP, 1% (10 mg/mL) and 2% (20 mg/mL). The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility.

Medicamen Biotech

Medicamen Biotech Limited's General Tablets and Liquid Orals Formulation facility located at SP 1192 A & B, Phase IV, Industrial Area, Bhiwadi has received the final approval (EU GMP Certification) from the Inspection Department, Division of Production & Distribution Control, National Organisation for Medicines, Greece.

Ajooni Biotech

Ajooni Biotech Limited has been awarded the BIS certification and ISI Mark for its mineral mixture, marking a significant milestone in our journey towards delivering top quality products. This certification not only reinforces the company's dedication to excellence but also ensures that the company meets the highest safety and quality standards in the market. This will greatly benefit farmers by ensuring they have access to high quality, reliable products that promote better livestock health and increased productivity.